• Save
MTM Presentation
Upcoming SlideShare
Loading in...5
×
 

MTM Presentation

on

  • 4,676 views

 

Statistics

Views

Total Views
4,676
Views on SlideShare
4,664
Embed Views
12

Actions

Likes
2
Downloads
0
Comments
0

3 Embeds 12

http://jujo00obo2o234ungd3t8qjfcjrs3o6k-a-sites-opensocial.googleusercontent.com 8
https://jujo00obo2o234ungd3t8qjfcjrs3o6k-a-sites-opensocial.googleusercontent.com 2
http://www.linkedin.com 2

Accessibility

Categories

Upload Details

Uploaded via as OpenOffice

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    MTM Presentation MTM Presentation Presentation Transcript

    • Pharmacists Improving Care and Reducing Costs image001 logo
    • Medication Therapy Management, LLC
      • Medication Therapy Services, LLC 235 Greenwood Street, Cranston, RI 02910 Phone 401-484-1479 * Fax 401-270-0378
      • Team of specially trained pharmacists
      • Out goal is our patient’s health and quality of life, NOT prescription volume allowing our pharmacists to treat our clients as patients, instead of a customers.
    • Scope of Medication-Related Problems
      • Significant impact on public health resulting from medication-related injury and death
      • More than 1.5 million preventable medication-related adverse events occur each year
      • Inappropriate use of medications costs an estimated $177 billion annually
      Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192 – 9. Institute of Medicine. Report Brief: Preventing Medication Errors. Washington, DC: Institute of Medicine; July 2006. http://www.iom.edu/Object.File/Master/35/943/medication%20errors%20new.pdf.
    • Medication-Related Problems $$$$ Increased Costs to the Health Care System $$$$ Increased Costs to Employers $$$$ Increased Insurance Premiums or Direct Costs dd_senior_drug_caution images
    • What Is Medication Therapy Management (MTM)?
      • Services provided by a pharmacist that improve treatment outcomes for individual patients
      • A professional service to promote the safe and effective use of medications
      • A way to provide better care for patients
        • Promotes collaboration among the patient, the pharmacist, and the patient’s other health care providers
      • Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc . 2005;45:566 – 72.
      • Who Needs Medication Therapy Management?
      MPj04223650000[1] understanding-diabetes-ga-2 Business-People asthma_child140
    • Where Are You Spending Your Health Care Dollars? Kaiser Family Foundation, 2007. http://www.kff.org/insurance/index.cfm
    • The Spectrum of Pharmacist-Provided MTM
      • Comprehensive or Targeted Medication Therapy Reviews
      • Adherence Services
        • Based on the number and/or type of medications
      • Targeted Medication Intervention Programs
        • High-alert and/or high-cost medications
        • Targeted patient population (i.e. geriatrics, pediatrics)
      • Disease State Management
        • Interdisciplinary approach to achieve therapeutic goals
        • Example disease states: Diabetes, Cholesterol, Asthma
      • Health and Wellness Services
        • Wellness screenings
        • Smoking cessation
    • MTM Core Elements Service Model Core Elements
      • Developed by the American Pharmacists Association and the National Association of Chain Drug Stores Foundation
      • Supported by 10 national pharmacy organizations
    • Components of the MTM Core Elements Service Model
      • Medication Therapy Review (MTR) – a review of all medications including prescription, nonprescription, herbal products, and other dietary supplements
      • Personal Medication Record (PMR)
      • Medication-Related Action Plan (MAP) for the patient
      • Intervention and/or Referral
      • Documentation and Follow-Up
    • Medication Therapy Reviews
      • A Medication Therapy Review (MTR) is a “Medication Check-Up” provided at routine intervals by a pharmacist
          • Annual comprehensive MTR
          • Additional comprehensive MTRs as needed
      • Targeted MTR at any time to address new or ongoing medication-related problems
      photo_06_News
    • What Do Patients Get From Care Aligned With the MTM Core Elements Model?
      • A complete list of all of their medications: Personal Medication Record (PMR)
      • A guide for managing their medications and related conditions: Medication-Related Action Plan (MAP)
    • Examples of MTM Interventions
      • Medication Adherence
        • Medication-related problem
          • Overuse of albuterol inhaler and suboptimal use of inhaled steroids in the treatment of asthma
        • Impact of MTM
          • Reduce ER visits, hospitalizations
      • Medication Interactions
        • Medication-related problem
          • Use of medications that can potentially increase the effect of warfarin (blood thinner)
        • Impact of MTM
          • Reduce risk of bleeding events, ER visits, and hospitalizations
    • Examples of MTM Interventions
      • Missing Therapy
        • Medication-related problem
          • Lack of therapy recommended by treatment guidelines
        • Impact of MTM
          • Better care and outcomes in alignment with evidence-based guidelines
      • Duplicate Medication Therapy
        • Medication-related problem
          • Two or more drugs treating the same condition
        • Impact of MTM
          • Coordination of care with multiple health care providers
          • Reduced risk of over-dosing due to additive effects
    • A Case Example From Our Practice
      • 55 yo male with Type 2 Diabetes
      • Duplication of Therapy: Prescribed two ACE inhibitors
        • Primary Care Physician (PCP): Lisinopril
        • Endocrinologist: Ramipril
      • Contacted both prescribers to make them aware of this medication related problem
      • Patient was continued on Ramipril
    • A Case Example From Our Practice
    • Goals of MTM Services
      • Patients
        • More medication-related problems identified and resolved
        • Empowered to take an active role in their medication management
      • Health Care Professionals
        • Improved transitions and continuity of care
        • Improved medication use outcomes
      • Payers
        • Reduction in adverse drug events
        • Potential to lower health care costs
    • MTM Services In Action
      • Minnesota Medication Therapy Management Care Program
      • The Asheville Project
    • Clinical Outcomes of MTM Minnesota MTM Care Program
      • 3.1 drug therapy problems identified and resolved per recipient
      • Most common drug therapy problems:
        • Dosage too low
        • Non-compliance
        • Need for additional drug therapy
      • Diabetes Subset (114 recipients):
        • 36% of patients with diabetes met all five of the state’s quality standards
        • Average hemoglobin A 1 C value was 7.38% (range 4.9%-14.7%, std dev. =1.82%)
        • 77% (88/114) of recipients with diabetes achieved hemoglobin A 1 C benchmark goal (less than or equal to 8%)
      Isetts BJ. Evaluating Effectiveness of the Minnesota Medication Therapy Management Care Program. Final Report. [Submitted December 14, 2007]. Available at: http://www.dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs16_140283.pdf
    • Clinical Outcomes of MTM The Asheville Project - Asthma Improved Asthma control sustained over 5 years Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133 – 47.
    • Clinical Outcomes of MTM The Asheville Project - Diabetes A1C < 7% Total Cholesterol < 200 mg/dl LDL < 100 mg/dl Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173 – 84.
    • Clinical Outcomes of MTM [customize this slide to meet the needs of your target audience - may include clinical outcomes from your practice or other specific clinical outcomes of interest to your audience]
    • Economic Outcomes of MTM Minnesota Medicaid MTM Care Program Decrease in :
      • Prescriber & non-prescriber provider costs
      • Ambulatory care costs
      • Lab & Diagnostic costs
      • Other costs
      Isetts BJ. Evaluating Effectiveness of the Minnesota Medication Therapy Management Care Program. Final Report. [Submitted December 14, 2007]. Available at: http://www.dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs16_140283.pdf
    • Total costs $9,035 $8,913 $8,802 $7,490 (N = 63) Year 3 Savings Per Patient from Projected Costs $6,250 from Baseline Costs $1,545 Yr 1 Projected $10,390 Year 3 Projected $13,740 Baseline $9,035 Year 2 Projected $11,948 APhA Foundation Patient Self-Management Program for Diabetes – Economic Impact Baseline, Years 1, 2, and 3 Compared With Projected Costs* Data provided by the APhA Foundation. *Projected increases based on multiple sources, not according to the ADA. Total medical expenditures incurred by people with diabetes were $13,243 per capita in 2002, compared with $2,560 for people without diabetes.
    • Economic Outcomes of MTM From Our Practice [ customize this slide to meet the needs of your target audience –include economic outcomes from analysis conducted in your own practice that may be of interest to your target audience]
      • American Pharmacists Association survey of pharmacist providers and payers
        • MTM implementation strategies
        • Value of MTM services
      • www.pharmacist.com/MTM
      APhA MTM Digest Examining the Value of MTM Services
      • Providers
        • E - mail survey conducted November/December 2007
        • Distributed to 6,873 providers who were likely to be involved with providing MTM
        • 687 respondents
      • Payers
        • E-mail survey conducted November/December 2007
        • Distributed to 1,898 individuals who were likely to be involved with payment for MTM and random sample
        • 132 respondents
        • 20 payers were selected for participation in an in-depth telephone interview (represented 18 distinct organizations)
      APhA MTM Digest Survey Methods
      • MTM services are being provided in diverse geographic areas and diverse care settings
      • MTM services are being offered and provided to patients in diverse populations (Medicaid, Medicare, commercial insured, self-insured, etc.)
      • Payers and providers anticipate positive impact of MTM on quality and value
      Overall APhA Survey Findings Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 1): provider perspectives in 2007. J Am Pharm Assoc. 2008;48:354 – 63. Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007. J Am Pharm Assoc. 2008;48:478 –86.
      • 10 respondents reported ROI for MTM programs
        • Ranged from 2:1 to 12:1
        • Median of 3:1
      • Reported actual amounts saved
        • $700,000/yr for 200 patients
        • (insurer/MTM vendor company)
        • $4.5 million/yr (self-insured employer)
      APhA Survey Findings of the Payer Perspective on Return on Investment (ROI) images Schommer JC, et al. Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007. J Am Pharm Assoc. 2008;48:478 –86.
    • APhA Survey Findings of Health Care Measures/Needs Addressed by MTM Services Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
    • APhA Survey Findings of Impact of MTM on Future Outcomes Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
    • Considerations for Providing MTM Services
      • Any patient who wants/needs MTM services should have access
      • Comprehensive Medication Therapy Reviews at least yearly – “Annual Medication Check-Up”
      • Targeted Medication Therapy Reviews available as needed to meet the needs of the individual patient
      • Additional MTM services should be considered for those patients needing them to maximum your ROI
    • Our MTM Service Offering
      • Medication Therapy Reviews (using the established MTM Core Elements Service Model)
        • Comprehensive Medication Therapy Reviews
        • Targeted Medication Therapy Reviews
      • Adherence Services
      • Targeted Medication Intervention Programs
      • Disease State Management
        • Diabetes, Asthma, Cholesterol
      • Health and Wellness Services
        • Wellness screenings
        • Immunizations
        • Smoking Cessation
    • [Insert Name of the MTM Practice (Pharmacy or Pharmacist)]
      • [insert content]
    • Billing, Compensation, and Reporting
      • Billing
        • Covered by some insurance plan, else self-pay
      • Compensation
        • Contact us for details, plans range depending on number of patients and types of services provided.
    • Billing, Compensation, and Reporting
      • [insert content]
    • Together we can…
      • Reduce the risk caused by medication-related problems
      • Improve care and outcomes
      • Help you reduce the health care costs
      • Optimize medication use and improve patients’ quality of life
    • Contact Information
      • Medication Therapy Services, LLC
      • 235 Greenwood Street, Cranston, RI 02910
      • Phone 401-484-1479
      • Fax 401-270-0378
      • [email_address]
    • Appendix to Slide Set (use/modify/incorporate into slide set if desired)
      • Patient Case Example
      • Clinical Outcomes Example
      • Economic Outcomes Example
      • Billing, Compensation, and Reporting Example
    • Clinical Outcomes of MTM Asthma Patients Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133–47. Link to full text: http://japha.metapress.com/link.asp?id=vr845p3l32384830
    • Economic Outcomes of MTM Decrease in yearly Rx cost to health plan (N = 7 patients) Rx cost to patient/year (N = 7 patients) McCarthy RA, Bennett MS, Green CG. Abstract: Medication therapy management services for a non-Medicare population: short-term assessment of economic, clinical, and humanistic outcomes. http://www.glprc.com/Abstracts/rptAbstracts%202006.pdf.